HIV--monoclonal antibody competition

UB-421 -- IV (Intravenous therapy)
Trogarzo/Ibalizumab (IZ)--IV
Leronlimab Not IV

UB-421 and Ibalizumab as long as given by IV will never be a competitive concern.